In the article entitled “Cord blood volume reduction using an automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyethyl starch sedimentation) for routine cord blood banking: a comparative study” V Lapierre, N Pellegrini, I Bardey, C Malugani, P Saas, F Garnache, E Racadot, S Maddnes and F Schillinger, published in Cytotherapy Vol 9, No. 2, pp 165–169, the last author is Maddens Stéphane and Françoise Schillinger is before the last author.
In the article entitled “Induction of potent antitumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation” J Zhang, W Qingqing, Z Dekuang, C Xuetao, published in Cytotherapy Vol 9, No. 4, pp 386–396, the sentence on p 387, Row 41, ‘Replication-defective recombinant adenoviruses vectors harboring the LacZ reporter gene (Ad-LacZ) and murine LIGHT gene (Ad-LIGHT) were constructed from human adenovirus serotype 5 using homologous recombination.’ should been changed to ‘Replication-defective recombinant adenoviruses vectors harboring the LacZ reporter gene (Ad-LacZ) and murine LIGHT gene (Ad-LIGHT) were kindly provided by Prof. Yangxin Fu (Chicago University, Chicago, MD, USA)’.